{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=EX&page=16", "query": { "intervention": "EX", "page": 16 }, "page_size": 10 }, "pagination": { "page": 16, "page_size": 10, "total_count": 603, "total_pages": 61, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=EX&page=17&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=EX&page=15&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-20T05:08:23.249Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05045794", "title": "Bridge to HOPE: Hypothermic Oxygenated Perfusion Versus Cold Storage Prior to Liver Transplantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "End Stage Liver DIsease", "Liver Failure" ], "interventions": [ { "name": "VitaSmart™Liver Machine Perfusion System", "type": "DEVICE" }, { "name": "Static cold storage", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Bridge to Life Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 228, "start_date": "2021-12-16", "completion_date": "2024-05-31", "has_results": true, "last_update_posted_date": "2026-07-22", "last_synced_at": "2026-10-20T05:08:23.249Z", "location_count": 15, "location_summary": "San Bernadino, California • San Francisco, California • Stanford, California + 12 more", "locations": [ { "city": "San Bernadino", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Weston", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05045794" }, { "nct_id": "NCT00107159", "title": "Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Melanoma (Skin)" ], "interventions": [ { "name": "autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Jonsson Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 37, "start_date": "2005-01", "completion_date": "2010-09", "has_results": false, "last_update_posted_date": "2013-11-06", "last_synced_at": "2026-10-20T05:08:23.249Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00107159" }, { "nct_id": "NCT06925542", "title": "A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "SLE (Systemic Lupus)", "Lupus Erythematosus, Systemic", "Lupus Nephritis", "Systemic Sclerosis", "Inflammatory Myopathy, Idiopathic", "Myositis", "Diffuse Cutaneous Systemic Sclerosis" ], "interventions": [ { "name": "CTX112", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "CRISPR Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 80, "start_date": "2025-03-10", "completion_date": "2031-12-31", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-10-20T05:08:23.249Z", "location_count": 9, "location_summary": "La Jolla, California • Redwood City, California • Chicago, Illinois + 6 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Redwood City", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT06925542" }, { "nct_id": "NCT01539486", "title": "Relationship of Preoperative Parathyroid Hormone (PTH) and Ex-Vivo Gamma Counts in Minimally Invasive Parathyroidectomy", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Parathyroid Disease" ], "interventions": [], "intervention_types": [], "sponsor": "University of Arkansas", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 29, "start_date": "2010-01", "completion_date": "2022-12", "has_results": false, "last_update_posted_date": "2023-09-15", "last_synced_at": "2026-10-20T05:08:23.249Z", "location_count": 1, "location_summary": "Little Rock, Arkansas", "locations": [ { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01539486" }, { "nct_id": "NCT00702741", "title": "Follow-up Study of Chondrogen® Delivered by Intra-Articular Injection Following Meniscectomy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Recovery Following Partial Medial Meniscectomy" ], "interventions": [ { "name": "Chondrogen", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mesoblast International Sàrl", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 55, "start_date": "2008-06", "completion_date": "2011-09", "has_results": false, "last_update_posted_date": "2022-01-11", "last_synced_at": "2026-10-20T05:08:23.249Z", "location_count": 4, "location_summary": "Los Angeles, California • Indianapolis, Indiana • Bloomington, Minnesota + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Bloomington", "state": "Minnesota" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00702741" }, { "nct_id": "NCT05400122", "title": "Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Colorectal Cancer", "Hematologic Malignancy", "Rectum Cancer", "Acute Myeloid Leukemia", "Myelodysplastic Syndromes", "Acute Lymphoblastic Leukemia", "Chronic Myeloid Leukemia", "Chronic Lymphocytic Leukemia", "Hodgkin Lymphoma", "Non Hodgkin Lymphoma", "Myeloproliferative Syndrome", "Plasma Cell Myeloma", "Gastric Cancer", "Esophageal Cancer", "Esophagus Cancer", "Gastric Cancer, Metastatic", "Unresectable Esophageal Cancer", "Metastatic Esophageal Cancer" ], "interventions": [ { "name": "Vactosertib", "type": "DRUG" }, { "name": "Fludarabine Phosphate", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "IL-2", "type": "DRUG" }, { "name": "Natural Killer Cells", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "David Wald", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2022-09-09", "completion_date": "2027-06-01", "has_results": false, "last_update_posted_date": "2026-07-14", "last_synced_at": "2026-10-20T05:08:23.249Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05400122" }, { "nct_id": "NCT02186418", "title": "Gene Transfer for Patients With Sickle Cell Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Anemia, Sickle Cell" ], "interventions": [ { "name": "ARU-1801", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 7, "start_date": "2014-07", "completion_date": "2022-10-31", "has_results": false, "last_update_posted_date": "2024-04-12", "last_synced_at": "2026-10-20T05:08:23.249Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02186418" }, { "nct_id": "NCT04293185", "title": "A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Sickle Cell Disease" ], "interventions": [ { "name": "bb1111", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "Genetix Biotherapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "2 Years to 50 Years" }, "enrollment_count": 35, "start_date": "2020-02-14", "completion_date": "2027-11", "has_results": false, "last_update_posted_date": "2024-12-10", "last_synced_at": "2026-10-20T05:08:23.249Z", "location_count": 9, "location_summary": "Birmingham, Alabama • Washington D.C., District of Columbia • Boston, Massachusetts + 6 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Hackensack", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04293185" }, { "nct_id": "NCT07121920", "title": "Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBD", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "IBD (Inflammatory Bowel Disease)", "IBD", "IBD - Inflammatory Bowel Disease" ], "interventions": [ { "name": "Confocal Laser Endomicroscopy", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Cook Children's Health Care System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "2 Years to 21 Years" }, "enrollment_count": 40, "start_date": "2025-09-01", "completion_date": "2028-07-01", "has_results": false, "last_update_posted_date": "2025-08-14", "last_synced_at": "2026-10-20T05:08:23.249Z", "location_count": 2, "location_summary": "Arlington, Texas • Fort Worth, Texas", "locations": [ { "city": "Arlington", "state": "Texas" }, { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07121920" }, { "nct_id": "NCT02385123", "title": "Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Influenza", "Influenza Immunisation" ], "interventions": [ { "name": "Influenza Virus Vaccine Inactivated", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 60, "start_date": "2015-04-01", "completion_date": "2020-12-31", "has_results": true, "last_update_posted_date": "2023-10-25", "last_synced_at": "2026-10-20T05:08:23.249Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02385123" } ] }